CoreAge Rx vs MadeMed
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MadeMed head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 86 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make MadeMed a bad call — it's best for people comfortable prepaying at least three months who want to compare the exact charge for their prescribed route. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | MadeMed |
|---|---|---|
| Brief Score | 94/100 (A) | 86/100 (B) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $239/mo injectable Quarterly prepay: $717 upfront; no monthly plan. Sublingual: $219/mo, $657 upfront quarterly. Six-month options cost less. Full price details$239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $399/mo injectable Quarterly prepay: $1,197 upfront; no monthly plan. Sublingual: $299/mo, $897 upfront quarterly. Six-month options cost less. Full price details$399/mo injectable and $299/mo sublingual on the quarterly plan ($1,197 / $897 in one charge); $369 and $279 on the 6-month plan. No month-to-month option |
| Coverage | US only; restrictions by state, confirmed at intake | Availability varies by treatment and state; confirm the selected product before prepaying |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
MadeMed: Each treatment route has a published price that stays the same across doses.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.